5th Annual Non-Coding RNA Symposium
The University of Illinois Chicago (UIC) College of Dentistry is holding its Annual Non-Coding RNA Symposium on September 12 – 13 at the UIC Molecular Biology Research Building Auditorium.
The Symposium is a global forum that brings together internationally renowned experts to highlight the latest developments in the field of basic and translational non-coding RNA research.
It aims to foster cross-collaborations between national and international researchers/clinicians and serve as a vital platform to accelerate the clinical utility of non-coding RNA-based diagnostics and therapeutics that can pave ways for precision medicine.
Speakers Include:
Eric C. Lai, PhD
Memorial Sloan Kettering Cancer Center
“RNAi and miRNAs: from mechanisms to biology”
His guiding research interest is to comprehend how complex biological patterns can be assembled with stereotyped precision during development. His lab utilizes integrative approaches to decipher genomic regulatory networks and their molecular mechanisms.
Bryan Cullen, PhD
Duke University
“How viruses subvert and co-opt miRNA-mediated gene regulation”
His laboratory studies the biogenesis and function of virus-encoded microRNAs. He is also interested in determining how epi-transcriptomic modifications affect viral replication and pathogenicity.
Anil Sood, MD
MD Anderson Cancer Center
“Therapeutic applications of non-coding RNAs”
His research is focused on understanding the mechanisms of angiogenesis and metastasis in ovarian cancer, effects of neuroendocrine stress hormones on ovarian cancer growth and progression, and development of new strategies for systemic in vivo siRNA delivery.
Jeff Coller, PhD
Johns Hopkins University
“Harnessing RNA to achieve precision gene therapy”
His research is focused on understanding the very essence of life: translation of the genetic code and has led to fundamental shifts in the understanding of gene expression. Coller’s lab investigates the exact signals at the end of mRNA translation and the beginning of mRNA degradation, which is not yet understood but holds great potential for novel therapeutics.